Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5691697 | Seminars in Nephrology | 2016 | 11 Pages |
Abstract
Although advances in immunosuppression and antimicrobial prophylaxis have led to improved patient and graft survival, respiratory viruses continue to be a common cause of morbidity and mortality in immunocompromised populations. We describe the clinical manifestations, diagnosis and treatment options for influenza, respiratory syncytial virus and adenovirus infection in the kidney transplant population.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Dana J. MD, Michael G. MD, MS, FIDSA, FAST,